… Despite radical treatment for clinically localized prostate cancer (PCa) with curative intent, …
of the primary tumor [1], [2], [3]. PCa recurrence is usually first suspected when a rise in serum …

… for the systematic review. The Oncotype Dx … natural history to provide perspective regarding
the tradeoff between treatment-related side effects and the likelihood of disease progression. …

… The long natural history of localised prostate cancer poses challenges in clinical trials designed
to improve overall survival. Moreover, the length of follow-up needed in therapeutic trials …

… Men newly diagnosed with localized prostate cancer (LPC) are facing difficult decisions
regarding treatment. They need to choose from a range of treatment options (eg, surgery, …

… grow, this Review summarizes current knowledge of the risks of financial toxicity in patients
with localized prostate cancer. The decision to concentrate on localized disease was made …

… tomography (PET/CT) suggests that occult distant metastases at presentation may be the
true driver of PCa natural history, especially for patients with National Comprehensive …

… The present review discusses the existing literature about … to treating localised prostate
cancer in any patient. As the … true incidence and natural history of prostate cancer in transgender …

… on the OS and natural history of "Early prostate cancer". In … The criteria is merely a
personal opinion derived from … of prostate cancer progression (secondary analysis of the …

… Outcomes for men with localised prostate cancer managed with Active Surveillance (AS) …
review explore men's perceptions of the factors that influence their decision‐making process …

… Prostate cancer (PCa) is the second most common solid cancer and the fifth leading
cause of cancer … PCa is characterised by a relatively long natural history, and a substantial …